The Effect of the Exon-3-Deleted Growth Hormone Receptor on Pegvisomant-Treated Acromegaly: A Systematic Review and Meta-Analysis

Publisher： Karger

E-ISSN： 1423-0194|105|2|131-140

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.105, Iss.2, 2016-08, pp. : 131-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Exon 3-Deleted/Full-Length Growth Hormone Receptor Polymorphism and Response to Growth Hormone Therapy in Growth Hormone Deficiency and Turner Syndrome: A Multicenter Study

By  

Hormone Research in Paediatrics, Vol. 77, Iss. 2, 2012-03 ,pp. : 85-93

Karger

Access to resources Recommend Favorite

Growth Hormone Receptor Exon 3 Isoforms and Their Implication in Growth Disorders and Treatment

By  

Hormone Research in Paediatrics, Vol. 71, Iss. 2, 2009-04 ,pp. : 55-63

Karger

Access to resources Recommend Favorite

Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis

By  

European Thyroid Journal, Vol. 6, Iss. 4, 2017-01 ,pp. : 208-215

Karger

Access to resources Recommend Favorite

Expression of Growth Hormone Receptor Isoform Exon-3-Excluding and Exon-3-Retaining Messenger RNAs in Peripheral Lymphocytes from Normal and Acromegalic Subjects

By  

Hormone Research in Paediatrics, Vol. 60, Iss. 2, 2003-07 ,pp. : 68-72

Karger

Access to resources Recommend Favorite

Pegvisomant Treatment in Acromegaly

By  

Neuroendocrinology, Vol. 103, Iss. 1, 2016-0 ,pp. : 59-65

Karger

Access to resources Recommend Favorite